GoldenGolden
Advanced Search
Nuon Therapeutics

Nuon Therapeutics

A company developing therapies for inflammation and neurological diseases

All edits by  Dawson Sewell 

Edits on 11 Apr, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 11 Apr, 2019
Edits made to:
Article (+17/-17 characters)
Article

On April 28, 2008 Nuon Therapeutics completed their series B funding round with $27 million in funding from Frazier Healthcare Partners and Domain AssociatesDomain Associates.

Edits on 2 Apr, 2019
Dawson Sewell
Dawson Sewell edited on 2 Apr, 2019
Edits made to:
Infobox (+5 properties)
Article (+682 characters)
Categories (+1/-2 topics)
Related Topics (+1 topics)
Article

Nuon Therapeutics is a biotechnology company developing therapies for inflammation and neurological diseases that is headquartered in San Mateo, California and was founded in 2002 by Lawrence Steinman.

Funding
Series A

On July 20, 2007 Nuon Therapeutics completed their series A funding round with $5 million in funding from GBS Ventures.

Series B

On April 28, 2008 Nuon Therapeutics completed their series B funding round with $27 million in funding from Frazier Healthcare Partners and Domain Associates.

Venture

On August 12, 2010 Nuon Therapeutics completed a venture capital round with $10 million in funding from GBS Ventures, Frazier Healthcare Partners, and Domain Associates.

Infobox
Location
United States
Industry
Date incorporated
2002
Categories
Related Topics
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.